For details see the When to Take section of the Protein Powder and Drinks Review
4-5 FDA APPROVED FOR 1-3 Gastrointestinal Strongyloidiasis Onchocerciasis OFF-LABEL DERMATOLOGIC USES Scabies Cutaneous demodicosis Refractory body/head lice Pediculosis palpebrarum Ocular and cutaneous rosacea Blepharitis Cutaneous larva migrans Cutaneous larva currens Myiasis Cutaneous gnathostomiasis Filariasis DOSING 8 Oral ivermectin dosing is variable depending on the condition being treated and the patients response
Cycling protocols of four to six weeks on, four to six weeks off align with the biology of connective tissue repair and represent a conservative default in the absence of long-term human safety data
Most RCTs enrolled heterogenous populations, including patients with hypoactive and/or hyperactive delirium, patients already experiencing sleep disruption, making it unclear whether there is a specific subgroup that could benefit from melatonin administration
BAC water is strongly preferred for this reason
A world where: One pathway is not your only chance If you cannot tolerate a GLP-1, you still have real hope Combination therapy becomes standard care, not wishful thinking This is what it looks like when we stop blaming patients and start treating physiology